Skip to content
Clinical Trials – home

DCC V Plovdiv EOOD

Research site

Bulgaria Trakia District, Ulitsa Siedinenie 42, 4023 Plovdiv, Bulgaria

  • 5 trials recruiting
  • Asthma · Bronchiectasis · COVID-19
  • Adults and children

About Specializations

DCC V Plovdiv EOOD in Plovdiv, Bulgaria specialises in clinical trials of conditions such as Asthma, Bronchiectasis, COVID-19, Chronic obstructive pulmonary disease, and other specialisations. This site conducts important research.

Main research areas of the site

Infectious Diseases

The medical center is at the forefront of research in infectious diseases, with a particular focus on SARS-CoV-2 (COVID-19) infection. The center is dedicated to advancing therapeutic options for patients who are at high risk for serious illness from COVID-19.

  • COVID-19 Treatment
  • Antiviral Therapies
  • Public Health Impact

Through rigorous clinical trials, the center evaluates the efficacy and safety of novel antiviral agents, contributing significantly to the global effort in managing and mitigating the impact of the pandemic.

Oncology

Specializing in oncology, the medical center is renowned for its research on unresectable or metastatic melanoma with a BRAF V600 mutation. The center's work is pivotal in exploring advanced treatment modalities for this aggressive form of cancer.

  • Melanoma Treatment
  • Targeted Therapies
  • Radiotherapy and Surgery

By investigating the progression-free survival of patients undergoing local treatments, the center enhances the understanding of therapeutic strategies, offering hope for improved patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Trakia District, Ulitsa Siedinenie 424023 PlovdivBulgaria
Recruiting now
5 trials
Conditions studied
5

More sites in PlovdivBulgaria

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

5 clinical trials

COVID-19

Recruiting

A study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Molnupiravir
  • Sponsor:Merck Sharp & Dohme LLC

Psoriasis

Recruiting

Long-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Bronchiectasis

Recruiting

Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis

Investigational
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:BI 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB

Asthma

Recruiting

GB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents

Investigational
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Generate Biomedicines Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.